Adding weekly GLP-1 to cognitive behavioral therapy further reduces heavy drinking
-
May 1, 2026
-
0 min
May 1, 2026
Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.
March 27, 2026
Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes
April 21, 2026
Investigators report site-specific cancer associations and limited adjusted estimates in meta-analysis.
April 6, 2026